General Diagnostics

  • Industry: Diagnostics
  • Status: Current
  • Year of investment: 2023

General Diagnostics

General Diagnostics (GD), a leading national player, provides comprehensive clinical diagnostic services to its partner franchisees, and its laboratory and hospital customers.

The Company’s services include haematology, pathology, immunology & serology, histology, newborn screening, medical microbiology, cytology, molecular diagnostics, and health screening packages.

GD uses proprietary algorithms and procedures, protected by intellectual property to deliver consistent, timely, cost effective, and reliable services to its partners.

Scroll to top